Volume 14, Issue 1 (Winter & Spring 2017)                   ASJ 2017, 14(1): 51-56 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shahraki Salar M, Arab M, Arab M R, Mashhadi M A, Sargolzaei Aval F, Mir M et al . Cisplatin Induce Urinary Space Obstruction and Tubular Necrosis in Rat Kidney. ASJ. 2017; 14 (1) :51-56
URL: http://anatomyjournal.ir/article-1-162-en.html
1- Department of Anatomy, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
2- Imam Ali Hospital, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
3- Department of Hematology and Oncology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Abstract:   (3281 Views)

Introduction: Cisplatin is a platinum based antineoplastic drug, which is widely used for treatment of solid tumors. The present investigation was carried out to study the nephrotoxic effects of double dose injection of cisplatin in rats, as an experimental model.
Methods: In this experimental study, 45 adult male Sprague Dawley rats with average weight of 200±30 g were randomly divided into two experimental (n=30) and one control (n=15) groups. Rats of experimental groups received two repeated doses of cisplatin intraperitoneally (2.5 mg/kg, experimental group E1 & 5 mg/kg, experimental group E2) in the beginning of first and fifth week of the experiment. Eight weeks after injection, rats of all groups were given deep anesthesia and killed. Blood samples were collected directly from their hearts for biochemical evaluation. Tissue samples were removed and prepared sections were stained with H&E, PAS, Masson trichrome, and PNA methods. Prepared microscopic slides were utilized for both histopathological and morphometrical studies. Collected data were analyzed by ANOVA and Tukey post hoc test using SPSS.
Results: Cisplatin administration induced a significant decrease in urinary space diameter of renal corpuscles in the experimental groups compared to the control group. This ultimately led to the urinary space obstruction in up to 95% of nephrons in experimental groups (P<0.001). There were significant difference between control and experimental groups (P<0.001) with regard to epithelial thickness of collecting duct, proximal and distal convoluted tubules. Moreover, there was a significant difference between control and experimental groups (P<0.001) with regard to the diameter of vasa recta. Acute tubular necrosis and urinary space obstruction were the main histological features of the experimental groups. There were also a significant elevation in serum level of BUN and creatinine in experimental group compared to those of control group.
Conclusion: Cisplatin induces acute tubular necrosis and urinary space obstruction and some other morphological changes in rat kidney, in a dose dependent manner.

Full-Text [PDF 548 kb]   (1103 Downloads)    
Type of Study: Original |
Received: 2016/03/12 | Accepted: 2016/10/28 | Published: 2017/01/1

1. Ozkok A, Edelstein CL. Pathophysiology of cisplatin induced acute kidney injury. BioMed Research International. 2014; 2014:1-17. doi: 10.1155/2014/967826 [DOI:10.1155/2014/967826]
2. Cavaletti G, Fabbrica D, Minoia C, Frattola L, Tredici G. Carboplatin toxic effects on the peripheral nervous system of the rat. Annals of Oncology. 1998; 9(4):443-47. doi: 10.1023/a:1008231925889 [DOI:10.1023/A:1008231925889]
3. Safirsteinr R, Miller P, Guttenplan JB. Uptake and metabolism of cisplatin by rat kidney. Kidney International. 1984; 25(5):753-58. doi: 10.1038/ki.1984.86 [DOI:10.1038/ki.1984.86]
4. Miller Roland P, Tadagavadi Raugh K, Ramesh G, Reeves WB. Mechanisms of Cisplatin Nephrotoxicity. Toxins. 2010; 2(11):2490-518. doi: 10.3390/toxins2112490 [DOI:10.3390/toxins2112490]
5. Arany I, Safirstein RL. Cisplatin Nephrotoxicity. Seminars in nephrology. 2003; 23(5):460-64. doi: 10.1016/s0270-9295(03)00089-5 [DOI:10.1016/S0270-9295(03)00089-5]
6. Daugaard G, Abildgaard U. Cisplatin nephrotoxicity. Cancer Chemotherapy and Pharmacology. 1989; 25(1):1–9. doi: 10.1007/bf00694330 [DOI:10.1007/BF00694330]
7. Spicer SS, Schulte BA. Detection and differentiation of glycoconjugates in various cell types by lectin histochemistry. Basic and Applied Histochemistry. 1988; 32(3):307-20. PMID: 3067702 [PMID]
8. Ravindra P, Bhiwgade A, Kulkarni S, Rataboli PV, Dhume CY. Cisplatin induced histological changes in renal tissue of rat. Journal of Cell and Animal Biology. 2010; 4(7):108-11.
9. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity. American Journal of the Medical Sciences. 2007; 334(2):115-24. doi: 10.1097/maj.0b013e31812dfe1e [DOI:10.1097/MAJ.0b013e31812dfe1e]
10. Choie DD, Longnecker DS, Campo del AA. Acute and chronic cisplatin nephropathy in Rats. Laboratory investigation. 1981; 44(5):397-402. PMID: 7194946 [PMID]
11. Saleh S, El-Demerdash E. Protective effects of Arginine against cisplatin induced renal oxidative stress and toxicity: role of Nitric Oxide. Basic & Clinical Pharmacology Toxicology. 2005; 97(2):91-97. doi: 10.1111/j.1742-7843.2005.pto_114.x [DOI:10.1111/j.1742-7843.2005.pto_114.x]
12. Ortega LM, Fornoni A. Role of cytokine in pathogenesis of acute and chronic kidney disease, glomerrolonephritis, and end stage kidney disease. International Journal of Interferon, Cytokine and Mediator Research. 2010; 2(1):49-62. doi: 10.2147/ijicmr.s10111 [DOI:10.2147/IJICMR.S10111]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb